Thought i would change the thread to more reflect on the Antisense business model ATL1103 for cancer diabetes and acromegaly.(all in huge demand gobally).
http://somavert.com/
Pfizer own this drug and you can research for yourselves the enormity of Somavert.
If ATL1103 can deliver the clinical success as shown in Primates and after lots of research i believe we do have a 95% success rate in my viw, imagine the huge market demand for Antisense ATL1103. Globally it will be huge and ATL1103 should have a very good toxiclogy. In my view we are about to hit the big time.ISIS firmly on boardas a partner.Awaiting Clinical trial results eagerly. Robbbbsssttarrrrr
